Therefore, based on our clinical observation of its prognostic value, we hypothesized that P2RX1 activation could exploit this Ca2+-mitochondria-apoptosis axis to exert anti-leukemic effects in Ph+ ALL. Here, P2RX1 is linked to acute lymphoblastic leukemia.